Clinical trial
Trial of Treatment of Vasospasm Associated With Aneurysmal Subarachnoid Hemorrhage With Intrathecal Injection of Nicardipine: a Multi-center, Prospective, Double-blinded, Randomized Controlled Trial
NCT06329635 is registered in ClinicalTrials.gov with The Affiliated Hospital Of Guizhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial of Treatment of Vasospasm Associated With Aneurysmal Subarachnoid Hemorrhage With Intrathecal Injection of Nicardipine: a Multi-center, Prospective, Double-blinded, Randomized Controlled Trial
- Lead sponsor
- The Affiliated Hospital Of Guizhou Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 27, 2024
- Completion date
- May 31, 2026
- Enrollment
- 396 (estimated)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.
aneurysmal subarachnoid hemorrhage, vasospasm